A randomized, double‐blind, placebo‐controlled study of the kappa opioid receptor antagonist, CERC‐501, in a human laboratory model of smoking behavior-Reference-Cited by-同舟云学术

A randomized, double‐blind, placebo‐controlled study of the kappa opioid receptor antagonist, CERC‐501, in a human laboratory model of smoking behavior

Published:2019-06-26 Issue:4 Volume:25 Page:
ISSN:1355-6215
Container-title:Addiction Biology
language:en
Short-container-title:Addiction Biology

Author:

Jones Jermaine D.¹,Babalonis Shanna²,Marcus Ronald³,Vince Bradley⁴,Kelsh Debra⁴,Lofwall Michelle R.²,Fraser Heather⁵,Paterson Blake⁶,Martinez Suky¹⁷,Martinez Diana M.¹,Nunes Edward V.¹,Walsh Sharon L.²,Comer Sandra D.¹

Affiliation:

1. Division on Substance Use Disorders New York State Psychiatric Institute and Columbia University Vagelos College of Physicians and Surgeons New York City New York USA

2. Department of Behavioral Science, Center on Drug and Alcohol Research University of Kentucky Lexington Kentucky USA

3. Supernus Pharmaceuticals Rockville Maryland USA

4. Vince and Associates Overland Park Kansas USA

5. Cerecor Inc Baltimore Maryland USA

6. NRZ Consulting Baltimore Maryland USA

7. Translational Research Training Program in Addiction City College of New York New York City New York USA

Funder

National Institute on Drug Abuse

Cerecor

Publisher

Wiley

Subject

Psychiatry and Mental health,Pharmacology,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/adb.12799

Reference47 articles.

1. Current Cigarette Smoking Among Adults — United States, 2005–2014

2. United Nations Office on Drugs and Crime World Drug Report.(United Nations publication Sales No. E.16. XI. 7).2016.

3. Pharmacotherapy for Nicotine Dependence

4. Pharmacological Intervention of Nicotine Dependence

5. Varenicline for smoking cessation: A review of the literature

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical and clinical efficacy of kappa opioid receptor antagonists for depression: A systematic review;Journal of Affective Disorders;2024-10

2. Novel medications for problematic alcohol use;Journal of Clinical Investigation;2024-06-03

3. Comorbid alcohol use disorder and posttraumatic stress disorder: A proof‐of‐concept randomized placebo‐controlled trial of buprenorphine and naltrexone combination treatment;Alcohol: Clinical and Experimental Research;2023-08-30

5. Alleviation of Cocaine Withdrawal and Pertinent Interactions between Salvinorin-Based Antagonists and Kappa Opioid Receptor;ACS Chemical Neuroscience;2023-02-16